Advanced pair fast forward to merger
This article was originally published in Clinica
Advanced NMR and its subsidiary Advanced Mammography Systems are to merge. Advanced Mammography shareholders will receive around $7.2 million worth of Advanced NMR stock, valued at $2.50 after a proposed one for ten proposed reverse stock split is effected. Advanced Mammography's shareholders will own around 40% of the new company.
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.